Europe's drug supply chain exposed: 90% of key medicine components sourced from China, India

A journalist's analysis highlights Europe's heavy reliance on China and India for active pharmaceutical ingredients, including for common drugs like ibuprofen and antibiotics. The report underscores the strategic vulnerability of Europe's pharmaceutical supply chain and the economic and environmental hurdles to reshoring production. This is a continuation of known supply-chain concerns, but the explicit 90% figure and focus on essential medicines elevate its policy relevance.